About Immune

Immune Pharmaceuticals Inc. (NASDAQ: IMNP) applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer.

The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma.

The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells.

The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors.

Immune is headquartered in the U.S., with its primary research and development facilities in Israel.

metformin bestellen strattera online where buy Alli cheap Metformin uk discount Lisinopril order no prescription Lisinopril where can i purchase Buspar online buy cod finpecia finpecia buy online in stock buy metformin cod Metformin buy cod buy generic Maxalt canada Maxalt for sale without prescription buy Maxalt 10mg where can i buy Maxalt over the counter where can i purchase Buspar no rx buy Premarin doctor prescription buy Metformin epharmacist Metformin uk prezzo Maxalt prednisone overnight US delivery buy cytotec oral Cytotec purchase overnight delivery